Myriad Genetics, Inc. · NASDAQ:MYGN
Glenview Capital Management, LLC reported a 5.30% stake in Myriad Genetics, Inc. (Schedule 13G)
Event Jan 6, 2026 · Filed Jan 13, 2026
Glenview Capital Management, LLC reported a 5.30% stake in Myriad Genetics, Inc., 4,941,058 shares, as a passive investor on Jan 6, 2026. Filed Jan 13, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 4,941,058
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| GLENVIEW CAPITAL MANAGEMENT, LLC | 5.30% | 4,941,058 |
| ROBBINS LARRY | 5.30% | 4,941,058 |
Source
Related
- Myriad Genetics, Inc.
- Glenview Capital Management, LLC
- Myriad Genetics, Inc. shareholders
- Schedule 13G/A · Glenview Capital Management, LLC · Aug 14, 2026
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026